Sale!

POMGNT1 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The POMGNT1 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A3 (MDDGA3) genetic test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the POMGNT1 gene. This gene plays a critical role in the development and functioning of muscles, brain, and eyes. Mutations in the POMGNT1 gene are associated with a rare form of muscular dystrophy known as MDDGA3, characterized by congenital muscular dystrophy coupled with brain and eye anomalies.

This comprehensive test is crucial for early diagnosis and management of MDDGA3, enabling healthcare providers to tailor specific treatment plans and interventions that can significantly improve the quality of life for affected individuals. The test cost is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic mutations associated with this condition. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and commitment to providing accurate and actionable health information, this test represents a critical step forward for patients and families facing the challenges of MDDGA3.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

POMGNT1 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A3 Genetic Test

Test Name: POMGNT1 Gene Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for POMGNT1 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with POMGNT1 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3.

Test Details: The POMGNT1 gene is associated with a rare genetic disorder called muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3. This disorder is characterized by muscle weakness and wasting (muscular dystrophy), as well as abnormalities in the brain and eyes. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of POMGNT1 gene testing, NGS can be used to identify mutations or variations in the POMGNT1 gene that may be responsible for the development of muscular dystrophy-dystroglycanopathy, type A3. Genetic testing for POMGNT1 gene mutations can help in confirming a diagnosis, predicting the likelihood of passing on the disorder to offspring, and guiding appropriate management and treatment options. It is typically recommended for individuals with symptoms suggestive of muscular dystrophy-dystroglycanopathy, type A3, or those with a family history of the condition. If you have concerns about this genetic disorder or are considering genetic testing, it is recommended to consult with a healthcare professional or a genetic counselor who can provide personalized information and guidance based on your specific situation.

Test Name POMGNT1 Gene Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for POMGNT1 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with POMGNT1 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3
Test Details

The POMGNT1 gene is associated with a rare genetic disorder called muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3. This disorder is characterized by muscle weakness and wasting (muscular dystrophy), as well as abnormalities in the brain and eyes.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of POMGNT1 gene testing, NGS can be used to identify mutations or variations in the POMGNT1 gene that may be responsible for the development of muscular dystrophy-dystroglycanopathy, type A3.

Genetic testing for POMGNT1 gene mutations can help in confirming a diagnosis, predicting the likelihood of passing on the disorder to offspring, and guiding appropriate management and treatment options. It is typically recommended for individuals with symptoms suggestive of muscular dystrophy-dystroglycanopathy, type A3, or those with a family history of the condition.

If you have concerns about this genetic disorder or are considering genetic testing, it is recommended to consult with a healthcare professional or a genetic counselor who can provide personalized information and guidance based on your specific situation.